Patents by Inventor Tomas Lundin

Tomas Lundin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240150697
    Abstract: The present invention relates to a reconfigurable bioprocessing system (80) operable to perform a predetermined set of bioprocessing operations therein. The reconfigurable bioprocessing system (80) comprises a base unit (60) comprising a plurality of valve actuators (102). At least one of the plurality of valve actuators (102) is operable to releasably engage with at least part of a pinch valve cassette (103, 203) to control fluid flow through the pinch valve cassette (103, 203). At least part of the pinch valve cassette (103, 203) is removably attachable to the base unit (60) and the pinch valve cassette (103, 203) is provided adjacent to said plurality of valve actuators (102).
    Type: Application
    Filed: April 25, 2022
    Publication date: May 9, 2024
    Inventors: Klaus Gebauer, Tim Francois, Andreas Lundin, Bjorn Markus Olovsson, Kerstin Erickson, Tomas Dalmo
  • Patent number: 6706499
    Abstract: A medium is disclosed for embedding and preserving single cells or a cell tissue for an extended period of time at a temperature not exceeding 0° C. in a state suitable for DNA and/or RNA amplification, comprising an aqueous solution of at least one water-soluble cellulose derivative and, optionally, an osmotic pressure stabilizing agent. A method for preserving single cells or a cell tissue for an extended period of time at a temperature not exceeding 0° C. in a state suitable for DNA and/or RNA amplification using the above medium is also disclosed.
    Type: Grant
    Filed: November 13, 2001
    Date of Patent: March 16, 2004
    Assignee: Ascendia AB
    Inventors: Per Månsson, Tomas Lundin
  • Patent number: 6479283
    Abstract: A method for stimulating pancreatic cells to synthesize and/or excrete insulin comprises contacting insulin-producing cells, in particular their aqueous suspension, with a water-soluble cellulose derivative, in particular selected from alkylated, hydroxyalkylated, and alkylated-hydroxyalkylated cellulose or a mixture thereof. A medium for the culture of pancreatic &bgr;-cells contains an effective cell-stimulating amount of a cellulose derivative. It can be used to stimulate pancreatic &bgr;-cells to produce and/or excrete insulin. An apparatus for such stimulation comprises a container holding a solution of a cellulose derivative in an aqueous culture medium. Stimulation of pancreatic &bgr;-cells by a cellulose derivative is useful in the management of diabetes. Further preservative or therapeutic methods using the aqueous cellulose derivatives are disclosed.
    Type: Grant
    Filed: December 17, 1999
    Date of Patent: November 12, 2002
    Assignee: Ascendia AB
    Inventors: Per Månsson, Tomas Lundin, Christer Busch
  • Publication number: 20020150928
    Abstract: A medium is disclosed for embedding and preserving single cells or a cell tissue for an extended period of time at a temperature not exceeding 0° C. in a state suitable for DNA and/or RNA amplification, comprising an aqueous solution of at least one water-soluble cellulose derivative and, optionally, an osmotic pressure stabilizing agent. A method for preserving single cells or a cell tissue for an extended period of time at a temperature not exceeding 0° C. in a state suitable for DNA and/or RNA amplification using the above medium is also disclosed.
    Type: Application
    Filed: November 13, 2001
    Publication date: October 17, 2002
    Applicant: Ascendia AB
    Inventors: Per Mansson, Tomas Lundin